General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Amarin Pharma, Inc.(NONE) RESEARCH/RESEARCH GRANTS: NHLBI(NONE), AstraZeneca(NONE), Department of Defense (DoD)(MODEST), Duke Clinical Research Institute(NONE), Boehringer Ingelheim Pharmaceuticals, Inc(NONE), Cardurion Pharmaceuticals Inc(NONE)

View Full Disclosure